Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN2544113 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Plasminogen Activator, Tissue (PLAT) antibody
- Antibody type
- Polyclonal
- Description
- Protein A purified
- Reactivity
- Human
- Host
- Rabbit
- Isotype
- IgG
- Vial size
- 10 mg
- Storage
- Freeze on Arrival
Submitted references p75 neurotrophin receptor regulates tissue fibrosis through inhibition of plasminogen activation via a PDE4/cAMP/PKA pathway.
Human complement receptor type 1-directed loading of tissue plasminogen activator on circulating erythrocytes for prophylactic fibrinolysis.
Ethanol-withdrawal seizures are controlled by tissue plasminogen activator via modulation of NR2B-containing NMDA receptors.
Sachs BD, Baillie GS, McCall JR, Passino MA, Schachtrup C, Wallace DA, Dunlop AJ, MacKenzie KF, Klussmann E, Lynch MJ, Sikorski SL, Nuriel T, Tsigelny I, Zhang J, Houslay MD, Chao MV, Akassoglou K
The Journal of cell biology 2007 Jun 18;177(6):1119-32
The Journal of cell biology 2007 Jun 18;177(6):1119-32
Human complement receptor type 1-directed loading of tissue plasminogen activator on circulating erythrocytes for prophylactic fibrinolysis.
Zaitsev S, Danielyan K, Murciano JC, Ganguly K, Krasik T, Taylor RP, Pincus S, Jones S, Cines DB, Muzykantov VR
Blood 2006 Sep 15;108(6):1895-902
Blood 2006 Sep 15;108(6):1895-902
Ethanol-withdrawal seizures are controlled by tissue plasminogen activator via modulation of NR2B-containing NMDA receptors.
Pawlak R, Melchor JP, Matys T, Skrzypiec AE, Strickland S
Proceedings of the National Academy of Sciences of the United States of America 2005 Jan 11;102(2):443-8
Proceedings of the National Academy of Sciences of the United States of America 2005 Jan 11;102(2):443-8
No comments: Submit comment
No validations: Submit validation data